As of today (2024-05-21), Viela Bio's share price is $53.01.
Viela Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $-2.37. Hence, Viela Bio's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Viela Bio's Price-to-Free-Cash-Flow or its related term are showing as below:
VIE's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 32.97 * Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
The historical data trend for Viela Bio's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Viela Bio's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, Viela Bio's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viela Bio's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viela Bio's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Viela Bio's Price-to-Free-Cash-Flow falls into.
Viela Bio Price-to-Free-Cash-Flow Calculation
Viela Bio's Price-to-Free-Cash-Flow ratio for today is calculated as
Viela Bio's Share Price of today is $53.01. Viela Bio's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Viela Bio (NAS:VIE) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Viela Bio Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Viela Bio's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIE has been successfully added to your 